Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...
Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...
GlobalData on MSN4d
Globus Medical strengthens SCS market position with $250m Nevro dealGlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
In a report released on February 7, Nathan Treybeck from Wells Fargo maintained a Hold rating on Nevro Corp (NVRO – Research Report), with a price target of $5.85. The company’s shares closed ...
But how you make it to that finish line is up to you. Some opt for manual support (see: fingers), others ask their partner(s) to do the work, and then there are the elite who use clit vibrators ...
After hours: February 11 at 6:00:01 p.m. EST ...
After hours: February 12 at 4:41:17 PM EST Loading Chart for NVNO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback